FDA approves new indication for Ozempic to lower kidney risks in type 2 diabetes, CKD

cafead

Administrator
Staff member
  • cafead   Jan 28, 2025 at 10:02: PM
via FDA approved semaglutide to lower the risk for worsening kidney disease, kidney failure and CV death in type 2 diabetes and CKD.

article source